OPTIMUM THERAPEUTICS
Optimum focuses on translating laboratory discoveries into clinical treatments by linking academic discoveries with commercial applications to benefit cancer research and patients. The company specializes in tumor priming technology to improve nanomedicine delivery and transport in solid tumors, utilizing approaches like tumor priming with standard chemotherapy.
Industries
Nr. of Employees
small (1-50)
Products
Tumor priming technology for enhanced delivery of nanomedicines
Approaches that use chemotherapy-based tumor priming to increase tumor interstitial transport and improve delivery and efficacy of nanoparticle- and microparticle-based therapeutics.
Tumor-penetrating microparticles for intraperitoneal therapy
Microparticle formulations designed to improve local delivery and efficacy of therapeutics administered intraperitoneally for ovarian and peritoneal malignancies.
Paclitaxel-loaded nanoparticle and gelatin nanoparticle formulations
Formulated nanoparticles containing paclitaxel intended to alter disposition and improve antitumor activity for site-directed and systemic applications.
siRNA delivery strategies enhanced by tumor priming
Lipid- and nanoparticle-based approaches to deliver siRNA therapeutics to tumors with improved transfection and expression when combined with tumor-priming methods.
Tumor priming technology for enhanced delivery of nanomedicines
Approaches that use chemotherapy-based tumor priming to increase tumor interstitial transport and improve delivery and efficacy of nanoparticle- and microparticle-based therapeutics.
Tumor-penetrating microparticles for intraperitoneal therapy
Microparticle formulations designed to improve local delivery and efficacy of therapeutics administered intraperitoneally for ovarian and peritoneal malignancies.
Paclitaxel-loaded nanoparticle and gelatin nanoparticle formulations
Formulated nanoparticles containing paclitaxel intended to alter disposition and improve antitumor activity for site-directed and systemic applications.
siRNA delivery strategies enhanced by tumor priming
Lipid- and nanoparticle-based approaches to deliver siRNA therapeutics to tumors with improved transfection and expression when combined with tumor-priming methods.
Services
Collaborative research to advance academic laboratory discoveries toward clinical and commercial applications in cancer therapy, including formulation, delivery, and preclinical evaluation.
Collaborative research to advance academic laboratory discoveries toward clinical and commercial applications in cancer therapy, including formulation, delivery, and preclinical evaluation.
Expertise Areas
- Nanomedicine formulation
- Tumor priming strategies
- Intraperitoneal and intravesical drug delivery
- siRNA therapeutic delivery
Key Technologies
- Nanoparticle drug delivery
- Microparticle drug delivery
- siRNA delivery systems
- Liposome formulation